GlassScriptPhysician profile
Kai H Hammerich
NPI 1639308810
$19,381.09
in general payments reported to CMS, 2019-2025
20 companies · $18K in 2025
The $18K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $185 · 2021: $175 · 2022: $269 · 2023: $235 · 2024: $140 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,600.00 |
| Food and Beverage | $903.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,757.71 | 2025 | |
| Calyxo, INC. | $371.14 | 2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $190.36 | 2019-2020 | |
| Teleflex LLC | $174.44 | 2023-2024 | Urolift |
| Tolmar Pharmaceuticals, INC. | $134.88 | 2019-2022 | |
| Procept Biorobotics Corporation | $132.52 | 2021 | |
| Laborie Medical Technologies Corp. | $94.49 | 2020-2023 | |
| Progenics Pharmaceuticals, INC. | $77.65 | 2022 | |
| Palette Life Sciences, INC. | $61.87 | 2022 | |
| Olympus America INC. | $58.35 | 2022-2023 | Itind System |
| C. R. Bard, INC. & Subsidiaries | $53.37 | 2020-2023 | Bard Urinary Drainage Bag |
| Allergan, INC. | $52.82 | 2019-2021 | |
| Rochester Medical Corporation | $50.81 | 2022 | |
| Antares Pharma, INC. | $43.06 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Sumitomo Pharma America, INC. | $42.47 | 2023 | Gemtesa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $21.55 | 2020 | |
| Axonics, INC. | $19.65 | 2023 | Axonics |
| Urogen Pharma, INC. | $14.72 | 2023 | Jelmyto |
| Pfizer INC. | $14.63 | 2019 | |
| Abbvie INC. | $14.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kai Hammerich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.